BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35838152)

  • 1. Investigation of the conformation of human prion protein in ethanol solution using molecular dynamics simulations.
    Xia K; Shen H; Wang P; Tan R; Xun D
    J Biomol Struct Dyn; 2023; 41(12):5872-5881. PubMed ID: 35838152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experiment and molecular dynamics simulations reveal proanthocyanidin B2 and B3 can inhibit prion aggregation by different mechanisms.
    Li Q; Zhu Y; Meng X; Tong HHY; Liu H
    J Biomol Struct Dyn; 2024 Mar; 42(5):2424-2436. PubMed ID: 37144732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replica Exchange Molecular Dynamics Study of Dimerization in Prion Protein: Multiple Modes of Interaction and Stabilization.
    Chamachi NG; Chakrabarty S
    J Phys Chem B; 2016 Aug; 120(30):7332-45. PubMed ID: 27390876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How graphene affects the misfolding of human prion protein: A combined experimental and molecular dynamics simulation study.
    Zhu Y; Guo J; Zhang A; Li L; Liu X; Liu H; Yao X
    Environ Res; 2019 Apr; 171():1-10. PubMed ID: 30641367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation-Dependent Refolding of Prion Protein Unveils Amyloidogenic-Related Structural Ramifications: Insights from Molecular Dynamics Simulations.
    Palaniappan C; Narayanan RC; Sekar K
    ACS Chem Neurosci; 2021 Aug; 12(15):2810-2819. PubMed ID: 34296847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular dynamics studies on the buffalo prion protein.
    Zhang J; Wang F; Chatterjee S
    J Biomol Struct Dyn; 2016; 34(4):762-77. PubMed ID: 26043781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of Strain Diversity of Disease-Associated in-Register Parallel β-Sheet Amyloids and Implications About Prion Strains.
    Taguchi Y; Otaki H; Nishida N
    Viruses; 2019 Jan; 11(2):. PubMed ID: 30696005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular dynamics simulations of early steps in RNA-mediated conversion of prions.
    Alred EJ; Nguyen M; Martin M; Hansmann UHE
    Protein Sci; 2017 Aug; 26(8):1524-1534. PubMed ID: 28425641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of misfolding of the human prion protein revealed by a pathological mutation.
    Sanz-Hernández M; Barritt JD; Sobek J; Hornemann S; Aguzzi A; De Simone A
    Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33731477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human prion protein: exploring the thermodynamic stability and structural dynamics of its pathogenic mutants.
    Halder P; Mitra P
    J Biomol Struct Dyn; 2022; 40(21):11274-11290. PubMed ID: 34338141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular dynamics studies of dog prion protein wild-type and its D159N mutant.
    Zhang J
    J Biomol Struct Dyn; 2021 Aug; 39(12):4234-4242. PubMed ID: 32496928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temperature-Induced Misfolding in Prion Protein: Evidence of Multiple Partially Disordered States Stabilized by Non-Native Hydrogen Bonds.
    Chamachi NG; Chakrabarty S
    Biochemistry; 2017 Feb; 56(6):833-844. PubMed ID: 28102071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular dynamics studies on the NMR and X-ray structures of rabbit prion proteins.
    Zhang J; Zhang Y
    J Theor Biol; 2014 Feb; 342():70-82. PubMed ID: 24184221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for the complete resistance of the human prion protein mutant G127V to prion disease.
    Zheng Z; Zhang M; Wang Y; Ma R; Guo C; Feng L; Wu J; Yao H; Lin D
    Sci Rep; 2018 Sep; 8(1):13211. PubMed ID: 30181558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Destabilizing polymorphism in cervid prion protein hydrophobic core determines prion conformation and conversion efficiency.
    Hannaoui S; Amidian S; Cheng YC; Duque Velásquez C; Dorosh L; Law S; Telling G; Stepanova M; McKenzie D; Wille H; Gilch S
    PLoS Pathog; 2017 Aug; 13(8):e1006553. PubMed ID: 28800624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular prion protein gene polymorphisms linked to differential scrapie susceptibility correlate with distinct residue connectivity between secondary structure elements.
    Soto P; Claflin IA; Bursott AL; Schwab-McCoy AD; Bartz JC
    J Biomol Struct Dyn; 2021 Jan; 39(1):129-139. PubMed ID: 31900058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dynamics as an approach to study prion protein misfolding and the effect of pathogenic mutations.
    van der Kamp MW; Daggett V
    Top Curr Chem; 2011; 305():169-97. PubMed ID: 21526434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From molecular dynamics to quantum mechanics of misfolded proteins and amyloid-like macroaggregates applied to neurodegenerative diseases.
    Gillet JN
    J Mol Graph Model; 2022 Jan; 110():108046. PubMed ID: 34736057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural mechanisms of oligomer and amyloid fibril formation by the prion protein.
    Sengupta I; Udgaonkar JB
    Chem Commun (Camb); 2018 Jun; 54(49):6230-6242. PubMed ID: 29789820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the early stages of prion protein (PrP) aggregation with atomistic molecular dynamics simulations.
    Collu F; Spiga E; Chakroun N; Rezaei H; Fraternali F
    Chem Commun (Camb); 2018 Jul; 54(57):8007-8010. PubMed ID: 29967919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.